Biomarkers in ALS trials: from discovery to clinical utility

IntroductionMotor neuron disease (MND), also known as amyotrophic lateral sclerosis (ALS), is a progressive neurodegenerative disorder characterized by motor neuron degeneration, leading to muscle weakness, paralysis, and eventual respiratory failure. Despite advances in understanding its pathology,...

Cijeli opis

Bibliografski detalji

Glavni autori:	Triparna Roy, Ammar Al-Chalabi, Alfredo Iacoangeli, Ahmad Al Khleifat
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-11-01
Serija:	Frontiers in Neuroscience
Teme:	ALS (amyotrophic lateral sclerosis) MND (motor neuron disease) biomarker clinical trial (CT) neurodegenerative disease ALS
Online pristup:	https://www.frontiersin.org/articles/10.3389/fnins.2025.1636303/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!